Tag

SEC

7 stories

Biogen Paid $5.6B for Apellis; Filing Confirms Deal Terms

Biogen paid $5.6B for Apellis, and a new SEC filing confirmed the deal details CEO Chris Viehbacher has been engineering: a company that doesn't grow on…

Deals 6 days ago

Alamar Biosciences Files $159M IPO on 196% Revenue Growth

Alamar Biosciences wants $159 million from public markets, pricing 9.4 million shares at $15 to $17 apiece for a Nasdaq listing under "ALMR.

SEC Apr 9, 2026

Paid $2.4M to SEC: VC Fund Chief Settles Investor Fraud Claims

Nearly $2.4 million is the price a Florida-based VC fund chief agreed to pay the SEC to settle fraud claims.

SEC Apr 8, 2026

SEC Names Woodcock to Head 1,000-Person Enforcement Division

SEC Chairman Paul Atkins taps Gibson Dunn securities partner David Woodcock to lead the 1,000-person Enforcement Division, effective May 4, 2026.

Deals Apr 8, 2026

Merck Cut Terns Bid by $1B After Leukemia Data Missed

Merck cut its Terns offer from $7.7B to $6.7B after Phase 1 leukemia data disappointed. The rival bidder walked entirely.

SEC Apr 7, 2026

SEC's FY2025 Enforcement Take Was $2.7B, Not $17.9B

The SEC's FY2025 enforcement haul drops to $2.7B once you strip the Stanford Ponzi and parallel criminal proceeds from the $17.9B headline.

SEC Apr 7, 2026

SEC Paid $50M+ to One Whistleblower for Early Enforcement Tip

The SEC paid one whistleblower $50M+ for an early tip that triggered an enforcement action, implying at least $167M in underlying sanctions.